A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence

Completed · Phase 4

Conditions studied: HIV Infection

In brief

This study will enroll completers of a prior 24 week MEMS cap study of Kaletra adherence, conducted in 2005 - 2006, and repeat the MEMS monitoring for an additional 24 weeks in 2008/2009 on the current antiretroviral anchor drug. The goals of the study are to correlate long-term adherence with virologic outcome, and to explore the stability of MEMS cap adherence measurements over time.

Key facts

Study ID

NCT00785616

Run by

Montefiore Medical Center

People needed

55

Starts

2008-09-01

Expected to finish

2009-10-01

Last updated by the study team

2018-04-27

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participation in the prior Kaletra MEMS cap study

You may not qualify if…

• Not receiving antiretroviral therapy, refusal to provide informed consent

Where it is running

• Montefiore Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.